(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SUN PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SUN PHARMA

ST13

US500000087393253

Class

5

Filing

87393253

Registration

5410731

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

08/28/2024

Trademark type

Word

Nice classes

5

Filing date

03/30/2017

Registration date

02/27/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/28/2024

Last transaction

08/28/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

Mumbai, Maharashtra, IN

Examiner

CARROLL, DORITT

Current location

Historical data usage

Holders and representatives

Holders

Sun Pharmaceutical Industries Limited

Representatives

Craig Kuchii Sun Pharmaceutical Industries, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

House mark for pharmaceuticals

Publications

History of USPTO decisions and trademark events.

20 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/28/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/28/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/28/2024

E815

TEAS SECTION 8 & 15 RECEIVED

02/09/2024

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/27/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/27/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/12/2017

PUBO

PUBLISHED FOR OPPOSITION

12/12/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/22/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/04/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/03/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/02/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/02/2017

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

05/05/2017

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

05/05/2017

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

05/05/2017

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

05/05/2017

DOCK

ASSIGNED TO EXAMINER

04/28/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/05/2017

NWAP

NEW APPLICATION ENTERED

04/03/2017

Continuous trademark protection

Get notified about every new filing that threatens SUN PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.